Financials

  • Market Capitalization 146.08 M
  • Employee 61
  • Founded 1996
  • CEO N/A
  • Website www.acumenpharm.com
  • Headquarter Delaware, United States
  • FIGI BBG0058YJ317
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-1.05
Fiyat/satışlar oranı
638.93

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3674
MOLN
Molecular Partners AG - American Depositary Shares
3.79 USD-1.56%-7.79%-8.67%+1.88%153.02 M USD
3677
NBP
NovaBridge Biosciences - American Depositary Shares
1.32 USD-5.71%-4.35%-16.98%-70.73%152.30 M USD
3702
OTLK
Outlook Therapeutics, Inc. - Common Stock
0.59 USD-1.67%-1.67%-9.23%+43.03%143.63 M USD
3710
RNA
Atrium Therapeutics, Inc. - Common Stock
8.21 USD-2.26%+2.63%-20.83%-88.33%140.44 M USD

Haberler